Haynes Boone represented RedHill in the transaction. RedHill Biopharma Ltd. (NASDAQ: RDHL) announced an exclusive worldwide development and commercialization licensing agreement, excluding North America, for its...
RedHill’s Global Licensing Agreement with Hyloris
Rotunda Capital Partners’ Investment in Mama Lycha Foods
Greenberg Traurig advised Rotunda, while Haynes and Boone advised Mama Lycha on the transaction. Rotunda Capital Partners has invested in Mama Lycha Foods, in partnership with...
Morae’s Acquisition of Exigent
Haynes and Boone advised Morae Global Corporation on the transaction. Morae Global Corporation (“Morae”) announced its acquisition of Exigent Group Limited (“Exigent”). The acquisition of Exigent...
NextGen Healthcare’s Acquisition of TSI Healthcare
Haynes and Boone advised NextGen Healthcare, Inc. on the deal. NextGen Healthcare, Inc., a leading provider of innovative cloud-based healthcare technology solutions, announced its acquisition of TSI...
Clinigen Limited’s Acquisition of Drug Safety Navigator
Haynes and Boone advised Clinigen Limited on the deal. Clinigen Limited announced its acquisition of Drug Safety Navigator Inc. (DSN), a specialist pharmacovigilance service provider based in...